Monthly Archives: April 2013

Melbourne Senate Public Hearing: Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

On Monday, April 29, 2013 I’m appearing before a  Senate committee to give evidence about this bill put up by Greens Senator Richard Di Natale. The committee is looking at the need for regulation of pharmaceutical industry conduct with regards to interactions with the … Continue reading

Posted in Pharmaceutical Promotion, Senate | Tagged , | Leave a comment

Submission re Senate Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013

Now posted on the Senate web site along with others. Today is the last day for submissions so I guess more will show up next week.

Posted in Pharmaceutical Promotion, Senate | Tagged , | Leave a comment

Gave talk to ARCS Melbourne Regional Networking Group,

Self-regulation versus co-regulation: A consumer perspective. Noted that submissions to Greens Senator Di Natale Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013 should be lodged by 19 April 2013 to the Finance and Public Administration Legislation Committee. Reiterated that legislation is required to make compliance … Continue reading

Posted in Pharmaceutical Promotion, Senate | Tagged , , | Leave a comment